Thursday, June 20, 2013
Publication and contact
Leukotriene B4 (LTB4); complement 5 (C5)
mouse studies suggest inhibitors of both C5 and LTB4 could help treat
inflammatory diseases. In vitro, the tick-derived protein Ornithodoros
moubata complement inhibitor (OmCI)
bound both LTB4 and C5 and blocked their activation. In a mouse model for
antigen-induced acute lung injury, OmCI decreased neutrophil recruitment and
damage to pulmonary microvasculature compared with inhibition of Ltb4 or C5
alone. Next steps could include testing OmCI in additional animal models for
Cellceutix Corp.'s Kevetrin thioureidobutyronitrile,
an LTB4 and protein kinase B (PKB; PKBA;
AKT; AKT1) inhibitor, is in
Phase I testing to treat solid tumors.
Alexion Pharmaceuticals Inc.
markets Soliris eculizumab, a
humanized mAb targeting C5, to treat hemolytic uremic syndrome and paroxysmal
At least seven other companies have C5 inhibitors in Phase II testing or
earlier to treat various indications.
Published online June 20, 2013
Patent and licensing status
Roversi, P. et al. J.
Biol. Chem.; published online April 26, 2013;
Contact: Miles A. Nunn, Centre for Ecology and Hydrology,
All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]